Market Overview

Stocks Hitting 52-Week Highs

Share:
Related VRTX
JPMorgan, Canaccord Confident That Vertex's CF Drug Will Get FDA Approval
Vertex Shares Rally As FDA Panel Backs Orkambi; HC Wainwright Analyst Offers Thoughts
Lee Ainslie Adds 90 New Stocks to His Portfolio Within the First Quarter (GuruFocus)
Related IDXX
Worst Performing Industries For April 29, 2015
Worst Performing Industries For April 28, 2015

Vertex Pharmaceuticals (NASDAQ: VRTX) shares reached a new 52-week high of $95.02 after the company reported that its two phase 3 study of Lumacaftor in combination with ivacaftor met the primary endpoint.

IDEXX Laboratories (NASDAQ: IDXX) gained 2.19% to reach a new 52-week high of $135.53. Canaccord Genuity upgraded IDEXX from Hold to Buy and raised the price target from $116.00 to $148.00.

Intel (NASDAQ: INTC) shares rose 0.69% to touch a new 52-week high of $30.44. Intel's trailing-twelve-month revenue is $52.89 billion.

Yum! Brands (NYSE: YUM) shares gained 0.24% to touch a new 52-week high of $80.80. Yum's PEG ratio is 1.56.

Posted-In: 52-Week HighsNews Intraday Update Markets Movers

 

Related Articles (IDXX + INTC)

Around the Web, We're Loving...

Get Benzinga's Newsletters